Purchase Order 36C26126P0186
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $32,500 firm fixed-price purchase order to Edwards Lifesciences LLC on November 3, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract has no set-aside designation and is scheduled for completion by February 2, 2026, with performance taking place in San Francisco, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $43,151.47 firm fixed-price purchase order to Edwards Lifesciences LLC on December 16, 2025, for transcatheter aortic valve replacement (TAVR) prosthetics. This contract, which carries no set-aside designation, is scheduled for completion by January 15, 2026, with performance taking place in Palo Alto, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized...
- The Department of Veterans Affairs Veterans Health Administration awarded a $130,000 firm fixed price purchase order to Edwards Lifesciences LLC for the delivery of transcatheter aortic valve replacement (TAVR) surgical implants. Edwards Lifesciences LLC will perform as the prime contractor, with parent company Edwards Lifesciences Corporation. Delivery of the TAVR implants will occur between September 25, 2023 and October 31, 2023 to a location in San Francisco, California to support the VA's...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) equipment and related cardiovascular medical devices. The contract, issued on October 31, 2025, with performance in Minneapolis, Minnesota, represents a non-set-aside procurement of specialized heart valve technology. Edwards Lifesciences LLC, a leading manufacturer of advanced...
- Edwards Lifesciences LLC received a firm fixed-price purchase order valued at $32,500 from Veterans Integrated Service Network 21 for transcatheter aortic valve replacement (TAVR) surgical implants, with an ultimate completion date of February 11, 2026. The award was issued on November 12, 2025, with no set-aside designation and performance to be completed in San Francisco, California. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease medical...
- The U.S. Department of Veterans Affairs (VA) awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC, a for-profit limited liability company, for transcatheter aortic valve replacement (TAVR) services. The contract has a completion date of November 20, 2024 and does not utilize a set-aside designation. This award is part of Edwards Lifesciences LLC's broader work supporting the VA's Veteran Integrated Service Network (VISN) 23, which covers facilities in Minnesota. The...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) products on December 5, 2025, with completion scheduled for December 8, 2025. This contract, which carries no set-aside designation, will be performed in Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in...
- Edwards Lifesciences LLC has been awarded a $130,000 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide prosthetics heart valve transcatheter aortic valve replacement (TAVR) procedures and related services. The single award is for the delivery of transcatheter heart valves and associated care at VA medical facilities located in San Francisco, California, to support the VHA's surgical programs...
- The Department of Veterans Affairs Veterans Health Administration awarded a $34,000.00 firm-fixed-price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of transcatheter aortic valve replacement (TAVR) kits. The contract, which does not have a set-aside designation, has a completion date of May 20, 2024, and is part of the VA-VHA's efforts to provide specialized cardiovascular devices and services to support healthcare for veterans...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $34,000 purchase order to Edwards Lifesciences LLC for prosthetics surgical implant transcatheter aortic valve replacement (TAVR). Edwards Lifesciences LLC will perform the work as a division of its parent company, Edwards Lifesciences Corporation. The firm fixed price order is for a one day period of performance in Minneapolis, Minnesota from October 12-13, 2023. No set aside...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a purchase order to Edwards Lifesciences LLC on November 28, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants with a ceiling value of $32.5K. This firm fixed-price contract, which carries no set-aside designation, will be performed in San Francisco, California, and is scheduled for completion by December 1, 2025. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, serves as the prime contractor and sole manufacturer of the specialized heart valve products required under this award. Edwards Lifesciences LLC maintains a significant relationship with the VA through multiple prime contract vehicles, including two substantial Indefinite Delivery Contracts valued at $2.5M and $1.25M respectively, which support the agency's cardiovascular surgical capabilities across multiple Veterans Integrated Service Networks. The company specializes in providing advanced transcatheter heart valves and surgical implants, including SAPIEN and Inspiris Resilia products, essential for treating structural heart disease in the veteran population. This purchase order represents part of the company's ongoing commitment to supplying critical cardiovascular technologies that support the VA's mission to deliver specialized surgical care to veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 11/28/25 |